Biotech

All Articles

Amgen reports first stage 3 gain for $400M dermatitis drug

.Amgen has discussed (PDF) the initial stage 3 data on its $400 million dermatitis medication, conne...

Biogen, UCB record period 3 lupus gain after stopping working earlier test

.Biogen and also UCB's depend improving in to stage 3 astride a failed research tries to have actual...

Aptadir hopes new RNA preventions can reverse difficult cancers cells

.Italian biotech Aptadir Rehabs has launched along with the guarantee that its own pipeline of precl...

Wave surfs DMD excellence to regulatory authorities' doors, sending stockpile

.Wave Life Sciences has actually met its own goal in a Duchenne muscle dystrophy (DMD) research, ins...

Sanofi plucks new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, occupy...

Achilles drops cell treatment system, prepares for discharges after missing out on 'industrial stability' targets

.Achilles Rehabs has destroyed its own method. The English biotech is stopping work on its clinical-...

Aligos proclaims phase 2 MASH succeed, reducing liver excess fat as much as 46%

.Aligos Rehabs is actually trumpeting a midstage gain in metabolic-dysfunction associated steatohepa...

Basilea ratings $268M BARDA funding for antifungals, anti-biotics

.Basilea Pharmaceutica's job creating new antifungals has actually received a considerable improveme...

Capricor offers Europe civil liberties to late-stage DMD therapy for $35M

.Possessing actually gathered up the USA rights to Capricor Rehabs' late-stage Duchenne muscular dys...

FDA junks adcomm for Applied's unusual illness drug

.After pushing the choice meeting for Applied Therapies' metabolic condition drug govorestat, the FD...